Results 171 to 180 of about 10,259 (201)
Some of the next articles are maybe not open access.
Russian Journal of Bioorganic Chemistry, 2003
Interaction of the DNA type I topoisomerases from the murine and human placenta cells with nonspecific oligonucleotides was analyzed. The contributions of strong and week nonspecific electrostatic, van der Waals's, and hydrophobic interactions, and hydrogen bonding of the enzymes to the complex formation with the single- and double-stranded DNAs were ...
D V, Bugreev +3 more
openaire +2 more sources
Interaction of the DNA type I topoisomerases from the murine and human placenta cells with nonspecific oligonucleotides was analyzed. The contributions of strong and week nonspecific electrostatic, van der Waals's, and hydrophobic interactions, and hydrogen bonding of the enzymes to the complex formation with the single- and double-stranded DNAs were ...
D V, Bugreev +3 more
openaire +2 more sources
Studies on Type I and Type II DNA Topoisomerases From Mammalian Mitochondria
1993Mammalian mitochondria contain a unique DNA topoisomerase I with characteristics of both nuclear and bacterial type I DNA topoisomerases. This enzyme, purified from bovine liver, requires cations as cofactors and possesses optimal activity at pH 7.0, 37°C and either 150 mM K+ or Na+ ions.
openaire +1 more source
Cancer Research, 2010
Abstract Developing small molecule inhibitors in anti-cancer drug research is an integral part of clinical oncology. Gefitinib (Iressa) is a promising small molecule inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase. It was shown to have the potential to improve the clinical effectiveness of EGFR-targeted therapies and
Zeki Topcu, Isa Unlukurt, Sevil Zencir
openaire +1 more source
Abstract Developing small molecule inhibitors in anti-cancer drug research is an integral part of clinical oncology. Gefitinib (Iressa) is a promising small molecule inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase. It was shown to have the potential to improve the clinical effectiveness of EGFR-targeted therapies and
Zeki Topcu, Isa Unlukurt, Sevil Zencir
openaire +1 more source
Circulating Tumor DNA in Advanced Solid Tumors: Clinical Relevance and Future Directions
Ca-A Cancer Journal for Clinicians, 2021Heather Parsons +2 more
exaly
Structure of Eukaryotic Type I DNA Topoisomerase
1994T, Hsieh, M P, Lee, S D, Brown
openaire +2 more sources
Cancer Epigenetics in Clinical Practice
Ca-A Cancer Journal for Clinicians, 2023Veronica Davalos, Manel Esteller
exaly

